Vera Therapeutics Inc (VERA) — Strategic Asset Allocation Index
Vera Therapeutics Inc (VERA) has a Strategic Asset Allocation Index of 0.0% as of September 2023. Strategic assets (PP&E of $- plus long-term investments of $13.00K) total $13.00K, measured against net assets of $123.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Vera Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Vera Therapeutics Inc Strategic Asset Allocation Index (2021–2022)
This chart shows how Vera Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of September 2023, the index stands at 0.0%, representing strategic assets of $13.00K against net assets of $123.71 Million USD. For live market cap and overall valuation, see VERA market cap overview.
Annual Strategic Asset Allocation Index for Vera Therapeutics Inc (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Vera Therapeutics Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Vera Therapeutics Inc (VERA) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $109.00K | $51.00K | $58.00K | $76.91 Million | ▼ -1.1 pp |
| 2021 | 1.2% | $867.00K | $- | $867.00K | $69.59 Million | — |